Accueil • Veille Scientifique • Macrolide Resistance in MORDOR I – A Cluster-Randomized Trial in Niger
NEJM • 2019.06.06
Doan T., Arzika H.M., Hinterwirth A., Maliki R., Zhong L., Cummings S., Sarkar S., Chen C., Porco T.C., Keenan J.D., Lietman T.M., MORDOR Study Group
- Clinical trial
- International
- Azithromycin, Clinical trial, Macrolides, Niger, Streptococcus pneumoniae